Table 1 Clinical characteristics of the rapalogs induced interstitial pneumonitis
Medication | No. of cases | No. of interstitial pneumonitis (%) | Grade 3-4 (%) | Time to development (months) | |
|---|---|---|---|---|---|
Neoplastic disease | Everolimus | 107 | 7 (6.5) | 3 (2.8) | 5.8 |
Temsirolimus | 91 | 4 (4.4) | 1 (1.1) | 4.6 | |
Solid organ transplantation | Rapamycin | 107 | 5 (4.7) | 3 (2.8) | 8.6 |